Compartir
Información de la revista
Número
Vol. 29. Núm. S1.Abstracts of the 2023 Annual Meeting of the ALEH
(Febrero 2024)
Abstracts of the 2023 Annual Meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
Ann Hepatol. 2024;29 Supl 1:101187
Acceso a texto completo
P-1 EFFECTIVENESS AND SAFETY OF BARIATRIC SURGERY IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS SECONDARY TO METABOLIC ASSOCIATED FATTY LIVER DISEASE IN A TERTIARY REFERENCE HOSPITAL
Ana Luiza Gomes Reis, Marcella Motta Lucindo Duarte, Renato Gama Altike, Patrícia Momoyo Youshimura, Danilo Razente, Miller Barreto de Brito e Silva, Marco Aurélio Santo, Mário Guimarães Pessôa, Claudia Pinto Oliveira
Ann Hepatol. 2024;29 Supl 1:101187.1
Acceso a texto completo
P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
Samael Rodríguez, Rebeca Rosas, Angel Omar Vazquez, Ivonne Palacios, Ricardo De la Rosa, Rebeca Escutia, Josep Jiménez, Luis Felipe Jave, ... Juan Armendariz
Ann Hepatol. 2024;29 Supl 1:101187.2
Acceso a texto completo
P-3 PIRFENIDONE PREVENTS OBESITY-ASSOCIATED NONALCOHOLIC STEATOHEPATITIS AND CARDIAC FIBROSIS THROUGH HORMONAL REPROGRAMMING
Jorge Gutiérrez, Daniel López, Ana Soledad Sandoval, Ángel Omar Vázquez, Jonathan Samael Rodríguez, Juan Armendáriz
Ann Hepatol. 2024;29 Supl 1:101187.3
Acceso a texto completo
P-4 HETEROGENEITY OF PRE-LIVER TRANSPLANT EVALUATION PRACTICES IN LATIN AMERICA COUNTRIES: THE LIVER TRANSPLANT ALEH SPECIAL INTEREST GROUP, INTERNATIONAL SURVEY 2023
Victoria Mainardi, Josemaría Menéndez, Solange Gerona, Alejandra Villamil, Josefina Pages, Manuel Mendizabal, Sergio López, Adriana Varon, ... Rodrigo Zapata
Ann Hepatol. 2024;29 Supl 1:101187.4
Acceso a texto completo
P-5 APACHE STUDY DESIGN TO EVALUATE THE EFFICACY AND SAFETY OF PLASMA EXCHANGE WITH HUMAN SERUM ALBUMIN 5% ON SHORT-TERM SURVIVAL IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE AT HIGH RISK OF HOSPITAL MORTALITY.
Nikolaos Pyrsopoulos, Giovanni Perricone, Jasmohan S. Bajaj, Thierry Gustot, Thomas Reiberger, Mireia Torres, Peter Nelson, Javier Fernandez
Ann Hepatol. 2024;29 Supl 1:101187.5
Acceso a texto completo
P-6 PREVALENCE AND CLINICAL CHARACTERISTICS OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE IN MÉXICO
Erick Augusto Jasso, Jesús Alejandro Ruiz, Antonio Olivas, Luis Carlos Chávez, Juan Adrian Torres, Alfonso Fernández, Abraham Ramos, Josealberto Sebastiano Arenas, ... Aldo Torre
Ann Hepatol. 2024;29 Supl 1:101187.6
Acceso a texto completo
P- 7 RISK FACTORS FOR NON-ALCOHOLIC FATTY LIVER DISEASE AFTER LIVER TRANSPLANTATION
Marcelo Arouca, Rafael Mendes, Guilherme Grossi, Mateus Jorge, Henrique Drumond, Livia Manussakis, Luis Henrique De Oliveira, Leticia Chaves, ... Luciana Costa
Ann Hepatol. 2024;29 Supl 1:101187.7
Acceso a texto completo
P-8 OSTEOSARCOPENIA AND FIBROSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE
Débora Soares, Priscila Flores, Maria Auxiliadora Saad, Jenaine Rosa Emiliano, Raphael Moura, Rogério de Oliveira, Amanda Maria Felix, Jordanna Mendes, ... Carlos Roberto de Andrade
Ann Hepatol. 2024;29 Supl 1:101187.8
Acceso a texto completo
P-9 AUTOIMMUNE LIVER DISEASES IN LATIN AMERICA: A WEB-BASED SURVEY
Claudia Alves, Guilherme Grossi Lopes, Debora Raquel B, Eduardo Luiz Rachid, Daniela Chiodi, Javier Brahm, Carlos Bernardo Sánchez, Manuel Gatica, ... Mario Guimaraes
Ann Hepatol. 2024;29 Supl 1:101187.9
Acceso a texto completo
P-10 THE EFFECTS OF CHILEAN RESPONSE TO COVID-19 ON ALCOHOL CONSUMERS: A NATURAL POLICY EXPERIMENT
María Jesús Fuenzalida, Óscar Corsi, Valentina Cox, Luis Antonio Díaz, Juan Pablo Arab, Paula Margozzini, José Marín
Ann Hepatol. 2024;29 Supl 1:101187.10
Acceso a texto completo
P-11 PRIMARY BILIARY CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS HEPATIC OVERLAP SYNDROME – CASE REVIEW
Federico Aronsohn, Jaime Poniachik, Álvaro Urzúa
Ann Hepatol. 2024;29 Supl 1:101187.11
Acceso a texto completo
P-12 MELD 3.0 IS THE BEST PREDICTOR OF MORTALITY IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF)
Ernesto Javier Medina-Avalos, Fátima Higuera-de la Tijera, Miguel Yael Carmona-Castillo, Sandra Teutli- Carrión, Claudia Leticia Dorantes-Nava, José Luis Pérez-Hernández, Daniel Santana-Vargas
Ann Hepatol. 2024;29 Supl 1:101187.12
Acceso a texto completo
P-13 IMPACT OF SPONTANEOUS BACTERIAL PERITONITIS ON THE OUTCOME OF PATIENTS WITH HEPATIC CIRRHOSIS
Sandra Teutli, Claudia Leticia Dorantes, Miguel Yael Carmona, Ernesto Javier Medina, Daniel Santana, Maria De Fátima Higuera, Jose Luis Perez
Ann Hepatol. 2024;29 Supl 1:101187.13
Acceso a texto completo
P-14 SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS: PREVALENCE AND ANTIBIOTIC RESISTANCE PATTERNS
Bruno Campos, Eliabe Silva, Guilherme Grossi Lopes, Guilherme De Oliveira, Joao Pedro Rocha, Júlia Cunha, Laura Normando, Laura Melo, ... Cláudia Alves
Ann Hepatol. 2024;29 Supl 1:101187.14
Acceso a texto completo
P-15 HELICOBACTER PYLORI AS A RISK FACTOR FOR THE DEVELOPMENT OF MANIFEST ENCEPHALOPATHY AND OTHER COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS AT THE EUGENIO ESPEJO HOSPITAL IN THE PERIOD MAY 2019-JUNE 2022
Mariana Gabriela Orozco, Giadira Karolina Espinosa, Wilson Enrique Carrera, Wendy Patricia Calderón, Hugo Pereira
Ann Hepatol. 2024;29 Supl 1:101187.15
Acceso a texto completo
P- 16 HEPATOCELLULAR CARCINOMA IN CENTRAL AMERICA: A MULTIDISCIPLINARY APPROACH IN A COSTA RICAN COHORT
María Castro, Francisco Vargas, María Lynch, Aldo Carvajal, Esteban Cob, Daniel Mondragón, Víctor Alvarado, Alejandra Ochoa, ... Pablo Coste
Ann Hepatol. 2024;29 Supl 1:101187.16
Acceso a texto completo
P- 17 LIVER TESTS ABNORMALITIES AS PROGNOSTIC MARKERS OF DEATH IN PATIENTS HOSPITALISED BY COVID-19. A COHORT STUDY
Andrés Fernando Rodríguez, Sergio Mauricio Moreno, Camilo Andrés Duarte
Ann Hepatol. 2024;29 Supl 1:101187.17
Acceso a texto completo
P- 18 ANASTROZOLE MAY NOT BE ASSOCIATED FATTY LIVER DISEASE AND HEPATIC FIBROSIS IN WOMEN WITH BREAST CANCER
Mateus Jorge, Guilherme Grossi, Mísia Joyner De Sousa, Adriana Maria Lamego, Carolina Martins, Paulo Henrique Costa, Fernanda Alves, Julia Cunha, ... Claudia Alves
Ann Hepatol. 2024;29 Supl 1:101187.18
Acceso a texto completo
P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY
Francisco Idalsoaga, Luis Antonio Díaz, Oscar Corsi, Gustavo Ayares, Jorge Arnold, Winston Dunn, Yanming Li, Ashwani Singal, ... Juan Pablo Arab
Ann Hepatol. 2024;29 Supl 1:101187.19
Acceso a texto completo
P-20 OXIDATIVE STRESS MARKERS IN ALCOHOLIC LIVER DISEASE
GABRIELA GUTIÉRREZ, Abigail Hernandez, Zaira Medina, Marisela Hernandez, Moisés Martínez, José Luis Pérez, Fátima Higuera, Jacqueline Córdova
Ann Hepatol. 2024;29 Supl 1:101187.20
Acceso a texto completo
P-21 FIBROSIS DEVELOPMENT AND MALIGNANCIES ARE DELAYED BY PIRFENIDONE WHILE INCREASING SIRT1 NUCLEAR TRANSLOCATION AND HISTONE 3 DEACETYLATIONS IN A HEPATOCARCINOMA MODEL
Hugo Christian Monroy, Scarlet Arceo, Araceli Guadalupe Cabral, Marina Galicia, Juan Armendariz
Ann Hepatol. 2024;29 Supl 1:101187.21
Acceso a texto completo
P-22 UNCOVERING INSIGHTS ON ACUTE VARICEAL HEMORRHAGE: A CROSS- COUNTRY SURVEY STUDY ON THE MANAGEMENT OF UPPER GASTROINTESTINAL BLEEDING IN LATIN AMERICA
Jesus Ruiz, Wagner Enrique Ramirez, Antonio Olivas, Luis Carlos Chávez, Erick Jasso, Josealberto S. Arenas, Thamy Leidy Beltré, Jose Carlos Jésus Ticona, ... Luis Eduardo Zamora
Ann Hepatol. 2024;29 Supl 1:101187.22
Acceso a texto completo
P- 23 HEPATOCELLULAR CARCINOMA IN CENTRAL AMERICA: EPIDEMIOLOGY OF A COSTA RICAN COHORT
Francisco Vargas, María Lynch, María Castro, Aldo Carvajal, Esteban Cob, Victor Alvarado, Daniel Mondragón, Alejandra Ochoa, ... Pablo Coste
Ann Hepatol. 2024;29 Supl 1:101187.23
Acceso a texto completo
P- 24 DISTRIBUTION OF HEPATITIS C GENOTYPES IN THE ARGENTINE POPULATION IN THE LAST TEN YEARS
Javier Alejandro Sfalcin, Alan Gomez, Tomás Fernandez, Dolores Gagey, Pablo Gornitz, Andrea Lucca, Maribel Martinez Wassaf, Néstor Portela, ... Fabián Fay
Ann Hepatol. 2024;29 Supl 1:101187.24
Acceso a texto completo
P- 25 METABOLIC, HISTOLOGICAL AND INFLAMMATORY BENEFITS IN A MURINE MODEL OF ALCOHOLIC STEATOHEPATITIS USING METHYL-GROUP DONOR SUPPLEMENTATION
Carolina Diaz, Angel Omar Vázquez, Rebeca Rosas, Samael Rodriguez, Rebeca Escutia, Marina Galicia, Juan Armendariz, Ana Sandoval
Ann Hepatol. 2024;29 Supl 1:101187.25
Acceso a texto completo
P- 26 FIBROSIS FREQUENCY IN A COHORT OF METABOLIC FATTY LIVER DISEASE RISK PATIENTS
Priscila Flores, Débora Soares, Maria Auxiliadora Saad, Guillermo Cocavelarde, Carlos Roberto, Hévila Passos, Raphael Carreiro, Gabriela Machado, ... Ana Ester de Paula
Ann Hepatol. 2024;29 Supl 1:101187.26
Acceso a texto completo
P-27 DESCRIPTIVE STUDY ON PATIENTS WITH HEPATOCARCINOMA IN A PUBLIC HOSPITAL 2018-2023
Paula Andrea Huerta, Matías Alberto Salazar, Joaquín Jensen, Alexandra Ginesta
Ann Hepatol. 2024;29 Supl 1:101187.27
Acceso a texto completo
P-28 HEPATOTOXICITY OF PESTICIDES USED IN VITICULTURES IN THE SOUTHERN BRAZIL REGION
Nelson David Suarez, Sheila de Castro Cardoso, Raquel Boff, Patricia Gabriela Riedel, Camila Baldin, Franciele Fatima Lopes, Eduardo Natan Maraschin, Debora Silva, ... Dvora Joveleviths
Ann Hepatol. 2024;29 Supl 1:101187.28
Acceso a texto completo
P-29 INCIDENCE AND ASSOCIATED FACTORS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION IN A SINGLE CENTER IN PERU: A RETROSPECTIVE STUDY.
Williams Celedonio Campos, César Castro Villalobos, Rosario Mayorga Márquez, Jorge Garavito-Rentería, Rommel Zambrano- Huailla
Ann Hepatol. 2024;29 Supl 1:101187.29
Acceso a texto completo
P- 30 IMPACT OF SELF-REPORTED ANCESTRY IN HEPATOCELLULAR CARCINOMA IN HISPANIC POPULATIONS
Spencer Goble, Cindy Narvaez-Barbecho, Manaswita Tappata, Jhon Prieto, Domingo Balderramo, Enrique Carrera, Javier Diaz Ferrer, Marco Arrese, ... Jose Debes
Ann Hepatol. 2024;29 Supl 1:101187.30
Acceso a texto completo
P-31 METHOTREXATE SEEMS NOT TO BE ASSOCIATED WITH LIVER FIBROSIS IN RHEUMATOID ARTHRITIS PATIENTS
Leandro Augusto De Araújo, Maria Fernanda Brandão De Resende, Mateus Jorge, Guilherme Grossi, Sabrina Da Siva, Kassia Burini, Mateus Saraiva, Thais Galdino, ... Luciana Costa
Ann Hepatol. 2024;29 Supl 1:101187.31
Acceso a texto completo
P- 32 VALIDATION OF LILLE-4 VERSUS LILLE-7 TO PREDICT SHORT-TERM MORTALITY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS
Claudia Leticia Dorantes, María de Fátima Higuera, Alfredo Servín, Gabriela Gutiérrez, Miguel Yael Carmona, Sandra Teutli, Ernesto Javier Medina, José Luis Pérez
Ann Hepatol. 2024;29 Supl 1:101187.32
Acceso a texto completo
P- 33 FREQUENCY, PROPHYLAXIS AND MANAGEMENT OF VARICEAL BLEEDING IN PATIENTS WITH LIVER CIRRHOSIS IN A RETROSPECTIVE MULTICENTER COHORT FROM SOUTH AMERICA
Domingo Balderramo, Jhon Prieto, Javier Eslava, Juan Diego, María Teresita Carreño, Daniela Moreno, Robin German Prieto, Carlos Sanchez, ... Jose Debes
Ann Hepatol. 2024;29 Supl 1:101187.33
Acceso a texto completo
P- 34 TOMOGRAPHIC ASSESMENT OF SARCOPENIA IN CIRRHOTIC PATIENTS BEFORE LIVER TRASPLANT: PREVALENCE, ASSOCIATED FACTORS AND POST-SURGERY OUTCOMES IN A COHORT OF CHILEAN PATIENTS
Kenia Orellana, Francisca Araya, Abraham Gajardo, Giselle Arévalo, Isabel Lagos, Jaime Poniachik, Juan Pablo Roblero
Ann Hepatol. 2024;29 Supl 1:101187.34
Acceso a texto completo
P- 35 COMPLICATIONS ASSOCIATED TO THE LIVER TRANSPLANTATION IN PATIENTS WITH CIRRHOTIC CARDIOMYOPATHY
José Ignacio Ruiz, Verónica Marín, Daniela Simian, Pamela Smith, Juan Pablo Roblero, Álvaro Urzúa, Máximo Cattaneo, Marcelo Llancaqueo, ... Jaime Poniachik
Ann Hepatol. 2024;29 Supl 1:101187.35
Acceso a texto completo
P- 36 ACUTE ON CHRONIC LIVER FAILURE IN LATIN AMERICA: SUB-ANALYSIS OF A SYSTEMATIC REVIEW AND META-ANALYSIS
Gabriel Mezzano, Herman Edgardo Aguirre, Javier Perez-Valenzuela, Aaron Cortes, Adria Juanola, Andrés Cardenas, Elsa Sola, Ruben Hernaez
Ann Hepatol. 2024;29 Supl 1:101187.36
Acceso a texto completo
P- 37 CLINICAL EVOLUTION OF PATIENTS WITH AUTOIMMUNE LIVER DISEASES IN A LIVER TRANSPLANTATION CENTER
Harlim Rodríguez, Marcia Samada, Teresita Pérez, Lisset Barroso, Zucel Danay Cruz, Kenia Yunarkis Valenzuela, Lissette Chao, Yunia Tusen, Mirta Infante
Ann Hepatol. 2024;29 Supl 1:101187.37
Acceso a texto completo
P- 38 HEPATITIS E VIRUS IN PATIENTS WITH CHRONIC LIVER DISEASE IN COLOMBIA
Jhon Edison Prieto, Anabella Clara Fantilli, María Belén Pisano, Maribel Martínez, Octavio Giayetto, Domingo Balderramo, Viviana Elizabeth Re, Robin German Prieto, ... Andre Boonstra
Ann Hepatol. 2024;29 Supl 1:101187.38
Acceso a texto completo
P- 39 N-ACETYL CYSTEINE ATTENUATES ALTERATIONS GENERATED IN EXPERIMENTAL LIVER STEATOSIS INDUCED BY CHRONIC ALCOHOL CONSUMPTION PLUS A HYPERCALORIC DIET
Marina Galicia, Katia Berenice Roa, Angel Omar Vazquez, Hugo Christian Monroy, Rebeca Rosas, Ana Soledad Sandoval, Juan Armendariz
Ann Hepatol. 2024;29 Supl 1:101187.39
Acceso a texto completo
P- 40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY
Francisco Idalsoaga, Luis Antonio Diaz, Oscar Corsi, Gustavo Ayares, Jorge Arnold, Winston Dunn, Yanming Li, Ashwani Singal, ... Juan Pablo Arab
Ann Hepatol. 2024;29 Supl 1:101187.40
Acceso a texto completo
P-41 IMPACT OF CHOLEMIC NEPHROSIS ON RENAL FAILURE IN CIRRHOTIC PATIENTS
Silvia Johanna Lozada, María de Fátima Higuera, Daniel Santana, Leonardo Samuel Juarez, Cristhian Calderon, Carlos Barragan, Ricardo Garcia, Vilma Hernandez, Jose Luis Perez
Ann Hepatol. 2024;29 Supl 1:101187.41
Acceso a texto completo
P- 42 METABOLIC ASSOCIATED FATTY LIVER DISEASE AND BODY COMPOSITION MEASUREMENT
Maria Auxiliadora Nogueira, Priscila Flores, Debora Vieira, Rosa Leonora Salerno, Mariana Sophia Almeida Santos, Julio Alves, Maria Eduarda Costa, Aline De Araújo Sousa, ... Caroline Ramos
Ann Hepatol. 2024;29 Supl 1:101187.42
Acceso a texto completo
P- 43 HCV TESTING AND TREATMENT IN FOUR BRAZILIANS’ CORRECTIONAL SETTINGS
Joao Batista da Silva, Eric Soares, Alexandre Munhoz, Raquel Dalpaz Dias, Ana Paula Moraes da Silva Barrufi, Janieri Rosso Dassoler, Tiane Ramos do Canto, Thaís Alves Martins Candido, ... Patricia Rodrigues Oenning
Ann Hepatol. 2024;29 Supl 1:101187.43
Acceso a texto completo
P-44 OUTCOMES AND MORTALITY OF PATIENTS WITH HEPATOPULMONARY SYNDROME AT A QUATERNARY LIVER TRANSPLANT CENTER
Marcus Vinícius De Acevedo Garcia Gomes, Diogo Delgado Dotta, Juliana Marquezi Pereira, Roque Gabriel Rezende Lima, Evandro de Souza Oliveira, Luiz Augusto Carneiro D'Albuquerque, Carlos Viana Poyares Jardim, Patricia Kittler Vitorio, ... Débora Raquel Benedita Terrabuio
Ann Hepatol. 2024;29 Supl 1:101187.44
Acceso a texto completo
P-45 EVALUATION OF THE ALBI SCORE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH YTTRIUM-90 (90Y)
Stefanny Cornejo, Yailin Fabiola Velazquez, Blanca Zapote, Itzia Verduzco, Erika Santiago, Salvador Amezquita, Juan Salvador Garcia, Miguel Angel Mendoza, Eira Cerda
Ann Hepatol. 2024;29 Supl 1:101187.45
Acceso a texto completo
P- 46 AMOUNT OF DIETETIC FAT AND CARBOHYDRATE TYPES RELATED TO HEPATIC STEATOSIS IN A GROUP OF MEXICAN ADULTS
Sophia Eugenia Martínez, Graciela Elia Castro, Ashuin Kammar, Luis Uscanga
Ann Hepatol. 2024;29 Supl 1:101187.46
Acceso a texto completo
P- 47 ACCURACY OF MAFLD-S SCORE TO DIAGNOSE HEPATIC STEATOSIS IN A GROUP OF APPARENTLY HEALTHY PEOPLE.
Luis Carlos Chávez, Juan Adrián Torres, Sophía Eugenia Martínez, Ashuin Kammar, Antonio Olivas, Jesús Alejandro Ruiz, Luis Federico Uscanga, Graciela Castro
Ann Hepatol. 2024;29 Supl 1:101187.47
Acceso a texto completo
P- 48 EFFECT OF THE COMBINATION OF ORLISTAT AND L-CARNITINE ON THE QUALITY OF LIFE (SF.36) IN 16 OVERWEIGTH PATIENTS
Miguel Yael Carmona, Saúl André Vera, María De Fatima Higuera, Livan Delgado, Santiago Camacho
Ann Hepatol. 2024;29 Supl 1:101187.48
Acceso a texto completo
P- 49 DECOMPETATIONS CAUSING ADMISSION, READMISSION AND MORTALITY IN CIRRHOTIC PATIENTS ADMITTED AT EUGENIO ESPEJO SPECIALTY HOSPITAL. QUITO, ECUADOR
Walkenys Abigail Waldroph, Wilson Enrique Carrera
Ann Hepatol. 2024;29 Supl 1:101187.49
Acceso a texto completo
P- 50 VALIDATION OF S-ANT FOR THE DIAGNOSIS OF HEPATIC ENCEPHALOPATHY MINIMUM
Jose Luis Perez, Irais Alejandra Garcia, Maria De Fatima Higuera, Daniel Santana, Silvia Johanna Lozada, Leonardo Samuel Juarez, Diana Montemira, Christian Israel Hinojosa
Ann Hepatol. 2024;29 Supl 1:101187.50
Acceso a texto completo
P-51 SERUM MICRORNA EXPRESSION ACCORDING TO THE PRESENCE OF LIVER DISEASE AND SARS-CoV-2 INFECTION
Lucas Lima Da, Luciane Almeida Amado, Otacilio Da Cruz, Wagner Luis Da Costa Nunes Pimentel, Vanessa Duarte, Claudia Alexandra Pontes, Lia Laura, Vanessa Salete, ... Livia Melo
Ann Hepatol. 2024;29 Supl 1:101187.51
Acceso a texto completo
P- 52 CORRELATION AMONG DIFFERENT METHODS TO ESTIMATE BODY AND LIVER FAT IN HEALTHY ADULTS
Sophia Eugenia Martínez, Ashuin Kammar, Carlos Moctezuma, Graciela Elia Castro, Luis Uscanga
Ann Hepatol. 2024;29 Supl 1:101187.52
Acceso a texto completo
P- 53 NATURAL KILLER CELLS OF EARLY STAGES OF METABOLIC FATTY LIVER DISEASE PRESENT REDUCED CYTOTOXICITY AGAINST TUMOR CELLS. CASE- CONTROL ANALYSIS
Nixa Paola Olivares, Daniel Ernst, Maria Cecilia Poli, Gustavo Pinto, Francisca Allendes, Vanessa Oyarzún, Nancy Solis, Marco Arrese, ... Francisco Barrera
Ann Hepatol. 2024;29 Supl 1:101187.53
Acceso a texto completo
P-54 EVALUATION OF DAILY CLINICAL PRACTICE IN A CENTRAL AMERICAN COHORT WITH A DIAGNOSIS OF AUTOIMMUNE LIVER DISEASE: THEORY VS. PRACTICE
Alejandra Ochoa, Rosemary Sawyers, Aldo Carvajal, Álvaro Villaobos, , Carlos Campos, Mario Láscarez, Alessia Ávalos, ... Pablo Coste
Ann Hepatol. 2024;29 Supl 1:101187.54
Acceso a texto completo
P- 55 ACUTE LIVER FAILURE IN PERU: EPIDEMIOLOGY AND PROBLEMATIC OF SUPPORT AND MANAGEMENT
P. Martin Padilla, Carmen Cerron, Jaime Zegarra, Gustavo Matias, Mayra Galindo, Gelsing Vásquez, Anderson Solano, Javier Chian, ... Rosa Lopez
Ann Hepatol. 2024;29 Supl 1:101187.55
Acceso a texto completo
P- 56 TUBERCULOSIS IN LIVER TRANSPLANT RECIPIENTS: EXPERIENCE OF A SINGLE CENTER
Cárdenas Ramírez Bertha, Padilla-Machaca P. Martin, Cerrón Cabezas Carmen
Ann Hepatol. 2024;29 Supl 1:101187.56
Acceso a texto completo
P-57 CHARACTERIZATION OF HEPATOCELLULAR CARCINOMA AND ITS RELATIONSHIP WITH ALPHA-FETOPROTEIN LEVELS
Mayra Fernanda Beltran, Wilson Enrique Carrera, Jonathan David Alvarado, Jaysoom Willeem Abarca, Fabian Agustin Tulcanazo, David Napoleon Armas, Wendy Calderon, John Lata, ... Maria Jose Suarez
Ann Hepatol. 2024;29 Supl 1:101187.57
Acceso a texto completo
P- 58 CLINICAL OUTCOMES OF PATIENTS WITH GRAFT REJECTION FOLLOWING TRANSPLANTATION FOR AUTOIMMUNE LIVER DISEASE AT A LIVER TRANSPLANT CENTER IN COLOMBIA
Ximena Morales, Cristina Torres, Carolina Salinas, Martín Garzón, Geovanny Hernández, Oscar Beltrán, Gilberto Mejia, Andrés Murcia, ... Adriana Varón
Ann Hepatol. 2024;29 Supl 1:101187.58
Acceso a texto completo
P- 59 ROLE OF MARESINA-1 ON THE KIDNEY AND LIVER MORPHOLOGY ON A MURINE MODEL OF TYPE I DIABETES MELLITUS INDUCED WITH STREPTOZOTOCIN
Pamela Carolina Morales, Jessica Pamela Zúñiga, Ramón Norambuena, Daniel González
Ann Hepatol. 2024;29 Supl 1:101187.59
Acceso a texto completo
P-60 DIAGNOSTIC PERFORMANCE OF FIBROSCAN FOR LIVER DISEASE IN BOGOTA, COLOMBIA
Diana Del Pilar Torres, Benedicto Velasco, Jonathan Alexander Guezguan
Ann Hepatol. 2024;29 Supl 1:101187.60
Acceso a texto completo
P- 61 DRUG-INDUCED LIVER INJURY: REPORTING CHALLENGES AND ENZYMATIC CHANGES IN PATIENTS USING ANTIBIOTICS – RETROSPECTIVE STUDY
Nelson David Suarez, Raquel Boff, Vittoria Calvi, Paola Hoff, Sheila De Castro, Patricia Gabriela Riedel, Francielly Marques, Dvora Joveleviths
Ann Hepatol. 2024;29 Supl 1:101187.61
Acceso a texto completo
P- 62 RELAPSE OF AUTOIMMUNITY IN PATIENTS WITH LIVER TRANSPLANTATION FOR AUTOIMMUNE HEPATOPATHY AT A COLOMBIAN HEPATOLOGY CENTER
Ximena Morales, Cristina Torres, Carolina Salinas, Martin Garzón, Geovanny Hernández, Oscar Beltrán, Gilberto Mejía, Andrés Murcia, ... Adriana Varón
Ann Hepatol. 2024;29 Supl 1:101187.62
Acceso a texto completo
P- 63 UTILITY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN TREATING COMPLICATIONS OF PORTAL HYPERTENSION: EXPERIENCE IN UNIT OF LIVER TRANSPLANTATION IN URUGUAY
Romina Rey, Martin Elizondo, Juan Carlos Bandi, Marcelo Vicente Valverde, Solange Gerona
Ann Hepatol. 2024;29 Supl 1:101187.63
Acceso a texto completo
O-1 SEROPREVALENCE AND MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B AND C VIRUSES AMONG PREGNANT WOMEN IN A MATERNAL AND CHILDREN HOSPITAL FROM THE PROVINCE OF BUENOS AIRES
Rosana Solis, Mabel Mora, María Julieta Venturini, Fernando Battiston, Guadalupe Masci, Adrián Zapata, Laura Abojer, Martina Ribeky, ... MANUEL MENDIZABAL
Ann Hepatol. 2024;29 Supl 1:101187.64
Acceso a texto completo
O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Alexandre Araujo, Sophia Andreola, Leonardo Cezimbra, Vitoria Dal Agnol, Hugo Cheinquer, Jeronimo De Conto, Roberta Cabral, Carlos Thadeu, ... Mário Reis Álvares-Da-Silva
Ann Hepatol. 2024;29 Supl 1:101187.65
Acceso a texto completo
O-3 DEVELOPMENT OF LENTIVIRAL VECTORS FOR INHIBITION OF HEPATITIS B VIRUS VIA SMALL INTERFERING RNA
Barbara Lago, Giovana Angelice, Pedro Henrique Conceição, Vanessa de Paula, Maryrose Lavatori, Livia Villar, Elisabeth Lampe, Francisco Mello
Ann Hepatol. 2024;29 Supl 1:101187.66
Acceso a texto completo
O-4 MBOAT7 RS641738 IS ASSOCIATED WITH PROGRESSION TO CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN LATIN AMERICA
Spencer Goble, Joseph Akambase, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Mattos, Marco Arrese, Enrique Carrera, ... Jose Debes
Ann Hepatol. 2024;29 Supl 1:101187.67
Acceso a texto completo
O- 5 HCC RISK SCORE PRE AND POST SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED FOR CHRONIC HEPATITIS C
Marcus Vinícius de Acevedo Garcia Gomes, Diogo Delgado Dotta, Manuella Andrade Oliveira Sobral, Carla Brígido Oliveira, Isabela Bodaczny Taliberti, Nadjanine Linhares Casimiro, Glenda Alves Pereira Oliveira, André Luís Ferreira Bruder, ... Mário Guimarães Pessoa
Ann Hepatol. 2024;29 Supl 1:101187.68
Acceso a texto completo
O-6 EXPLORING THE IMPACT OF INFECTIONS IN PATIENTS WITH ALCOHOL- ASSOCIATED HEPATITIS IN LATIN AMERICA
Luis Antonio Díaz, Francisco Idalsoaga, Gustavo Ayares, Jorge Arnold, Katherine Maldonado, María Ayala, Diego Perez, Jaime Gomez, ... Juan Pablo Arab
Ann Hepatol. 2024;29 Supl 1:101187.69
Acceso a texto completo
O-7 CURRENT PRACTICE OF LIVER TRANSPLANTATION IN LATIN AMERICAN COUNTRIES: AN ALEH INTEREST GROUP SURVEY 2023
Paulo Bittencourt, Liana Codes, Adrian Gadano, Alejandra Villamil, Alfeu de Medeiros Fleck, Álvaro Urzua, Debora Raquel Terrabuio, Eira Cerda, ... Rodrigo Zapata
Ann Hepatol. 2024;29 Supl 1:101187.70
Acceso a texto completo
O- 8 PNPLA3 RS738409 C>G POLYMORPHISM IMPACT ON HCV-RELATED HCC DEVELOPMENT IN THE BRAZILIAN POPULATION: PRELIMINARY RESULTS
Claudia Maccali, Aline L Chagas, Lisa Rc Saud, Regiane Ssm Alencar, Michele Sg Gouvea, Joyce Mks Etto, Isabel V Pereira, Arthur In Oliveira, ... Claudia P Oliveira
Ann Hepatol. 2024;29 Supl 1:101187.71
Acceso a texto completo
O-9 PRESENCE OF METABOLIC ASSOCIATED LIVER DISEASE IN AUTOIMMUNE HEPATITIS IS ASSOCIATED WITH ADVANCED LIVER FIBROSIS
Giselle Arévalo, Daniela Simian, Jorge Chiong, Consuelo Palomo, Laura Carreño, Jaime Poniachik, Álvaro Urzúa
Ann Hepatol. 2024;29 Supl 1:101187.72
Acceso a texto completo
O-10 VALIDATION OF SERUM BIOMARKER PANELS FOR EARLY HCC DETECTION: RESULTS FROM A LARGE PROSPECTIVE LATIN AMERICAN MULTICENTER STUDY
Boris Beudeker, Siyu Fu, Domingo Balderramo, Angelo Mattos, Spencer Goble, Enrique Carrera, Javier Diaz, Jhon Prieto, ... Andre Boonstra
Ann Hepatol. 2024;29 Supl 1:101187.73
Acceso a texto completo
O-11 ENHANCEMENT OF F4/80+CD11B-CD206+ KUPFFER CELLS IN LIVER TISSUE: EFFECT OF MARESIN-1 AS HEPATOPROTECTIVE AGENT
Jessica Zuñiga, Andres Herrada, Francisca Herrera, Alexandra Olate
Ann Hepatol. 2024;29 Supl 1:101187.74
Acceso a texto completo
O-12 HELICOBACTER PYLORI VIRULENCE GENES ARE ASSOCIATED WITH NAFLD SEVERITY: A CROSS SECTIONAL STUDY IN DYSPEPTIC PATIENTS
Facundo Maiorana, Maria Virginia Caronia, Karina Elizondo, Magali Neschuk, Graciela Jorda, Adolfo Schneider, Pedro Dario Zapata, Fernando Javier Barreyro
Ann Hepatol. 2024;29 Supl 1:101187.75
Acceso a texto completo
O-13 SUB-OPTIMAL GLOBAL PUBLIC HEALTH POLICIES AND STRATEGIES TO TACKLE HEPATOCELLULAR CARCINOMA
Luis Antonio Díaz, Eduardo Fuentes, Blanca Norero, Oscar Corsi, Gustavo Ayares, Francisco Idalsoaga, Gonzalo Pizarro, Sergio García, ... OMEGA Collaborators
Ann Hepatol. 2024;29 Supl 1:101187.76
Acceso a texto completo
O-14 NON-ALCOHOLIC FATTY LIVER DISEASE IS INFLUENCED BY THE INTERACTION OF HELICOBACTER PYLORI INFECTION AND G-ALLELE OF PNPLA3
Facundo Maiorana, Magalí Neschuk, María Virginia Caronia, Adolfo Schneider, Georgina Veron, Pedro Dario Zapata, Fernando Javier Barreyro
Ann Hepatol. 2024;29 Supl 1:101187.77
Acceso a texto completo
O-15 MARESIN1 REVERSES CHRONIC LIVER FIBROSIS AND IMPROVES REGENERATION
Francisca Herrera, Matías Quiñones, Jessica Zúñiga
Ann Hepatol. 2024;29 Supl 1:101187.78
Acceso a texto completo
O-16 DIFFERENCES IN HEPATOCARCINOMA IN PATIENTS WITH CIRRHOSIS DUE TO NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) VS. OTHER ETIOLOGIES
Jimmy Sanga, Daniela Simian, Federico Aronsohn, Jaime Poniachik
Ann Hepatol. 2024;29 Supl 1:101187.79
Acceso a texto completo
O-17 NUTRICIONAL AND PHYSICAL THERAPHY IMPROVES LIVER FRAILTY INDEX IN LISTED PATIENTS WITH CIRRHOSIS: RANDOMIZED CONTROLLED TRIAL. INTERIM ANALYSIS
Diego Reyes, Carlos Benitez, Anny Galvez, Catalina Grandy, Nicolás Lavados, Isidora Cerda, Nicole Kim, Lucas Lacalle, ... Roberto Candia
Ann Hepatol. 2024;29 Supl 1:101187.80
Acceso a texto completo
O-18 DIFFERENCES IN BODY COMPOSITION OF MAFLD PATIENTS ACCORDING TO BODY MASS INDEX AND METABOLIC PROFILE
Eva Juárez, Iván López, Karen Bernal, Alain Velázquez, Andrea Maldonado, Martha Helena Ramos, Misael Uribe, Graciela Castro
Ann Hepatol. 2024;29 Supl 1:101187.81
Acceso a texto completo
O-19 IMPLICATIONS OF GLYPHOSATE ON NON-ALCOHOLIC FATTY LIVER DISEASE IN MICE
Guilherme Romualdo, Letícia Cardoso, Bruno Cogliati, De-Xing Hou, Luís Fernando Barbisan
Ann Hepatol. 2024;29 Supl 1:101187.82
Acceso a texto completo
O-20 EFFECTS OF ISOCALORIC AND NEGATIVE CALORIE BALANCE EXERCISE ON SERUM LEVELS OF INSULIN-LIKE GROWTH FACTOR TYPE 1 IN SUBJECTS WITH INITIAL AND ADVANCED FATTY LIVER
María Jesús Fuenzalida, Francisco Barrera, Hermann Mies, Valeria Correa, Francisca Allendes, Nancy Solis, Vanessa Oyarzún, Luis Antonio Díaz, ... Franco Godoy
Ann Hepatol. 2024;29 Supl 1:101187.83
Acceso a texto completo
O-21 NUTRITIONAL SUPPLEMENTATION WITH MEXICAN FOODS, OPUNTIA FICUS INDICA, THEOBROMA CACAO, AND ACHETA DOMESTICUS IMPROVED GUT-LIVER AXIS IN A MAFLD MICE MODEL.
Rebeca Rosas, Ana Soledad Sandoval, Ángel Omar Vázquez, Ricardo de la Rosa, Jonathan Samael Rodriguez, Rebeca Escutia, Arturo Santos, Juan Armendáriz
Ann Hepatol. 2024;29 Supl 1:101187.84
Acceso a texto completo
O-22 EFFICACY OF ATEZOLIZUMAB BEVACIZUMAB TREATMENT FOR HEPATOCELLULAR CARCINOMA IN REAL-WORLD CLINICAL PRACTICE AT TWO TERTIARY HEALTHCARE CENTERS IN SOUTHERN BRASIL: FIRST INTERIM ANALYSIS
Hugo Cheinquer, Alexandre Araujo, Mario Alvares-Da-Silva, Cristina Cheinquer, Jerônimo Oliveira, Ana Luiza Silva, Rui Fernando Weschenfeller
Ann Hepatol. 2024;29 Supl 1:101187.85
Acceso a texto completo
O- 23 STRATEGIES TO ELIMINATE HEPATITIS C VIRUS INFECTION IN THE AMERICAS
Luis Antonio Díaz, Sergio García, Rayan Khan, Gustavo Ayares, Javier Uribe, Francisco Idalsoaga, José Miguel Fuentealba, Eduardo Fuentes, ... Juan Pablo Arab
Ann Hepatol. 2024;29 Supl 1:101187.86
Acceso a texto completo
OP-1 FEATURES OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN LATIN AMERICA: LONG-TERM EXPERIENCE OF THE LATINDILI NETWORK
Fernando Bessone, Nelia Hernández, Maria I Schinoni, Manuel Mendizabal, Pedro Montes, Adriana Sanchez, Daniela Chiodi, Ezequiel Ridruejo, ... Raúl J Andrade
Ann Hepatol. 2024;29 Supl 1:101187.87
Acceso a texto completo
OP-2 ANALYSIS OF THE GENETIC DIVERSITY OF HEPATITIS DELTA VIRUS CIRCULATING IN BRAZIL BETWEEN 2013 AND 2021 AND ITS RELATIONSHIP WITH HEPATITIS B VIRUS
Giovana Angelice, Tairine de Barros, Livia Villar, Bárbara do Lago, Francisco Mello
Ann Hepatol. 2024;29 Supl 1:101187.88
Acceso a texto completo
OP-3 HCV MICROELIMINATION PROGRAM IN HEMODIALYSIS PATIENTS: SUCCESS OF A MULTI-STAKEHOLDER PARTNERSHIP BASED ON A NATIONAL ERADICATION STRATEGY
Ezequiel Ridruejo, Soledad Alonso, Gustavo Laham, Augusto Vallejos, Marcelo Oscar Silva, Marcelo Damian Ferder, Enrique Gabriel Dorado, Ezequiel Mauro, Marcelo Hugo Puddu
Ann Hepatol. 2024;29 Supl 1:101187.89
Acceso a texto completo
OP-4 DEVELOPMENT AND EXTERNAL VALIDATION OF A MODEL TO PREDICT MULTI-DRUG RESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS
Sebastian Marciano, Salvatore Piano, Virendra Singh, Paolo Caraceni, Rakhi Maiwall, Carlo Alessandria, Javier Fernandez, Dong Joon Kim, ... Paolo Angeli
Ann Hepatol. 2024;29 Supl 1:101187.90
Acceso a texto completo
Publique en
Annals of Hepatology
Contenido especial sobre COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
